Related references
Note: Only part of the references are listed.NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy
Han-Ming Shen et al.
APOPTOSIS (2009)
Biologic sequelae of IκB kinase (IKK) inhibition in multiple myeloma: therapeutic implications
Teru Hideshima et al.
BLOOD (2009)
Tumor Vasculature Is Regulated by PHD2-Mediated Angiogenesis and Bone Marrow-Derived Cell Recruitment
Denise A. Chan et al.
CANCER CELL (2009)
Stromal cell-derived factor-1α (SDF-1α/CXCL12)-enhanced angiogenesis of human basal cell carcinoma cells involves ERK1/2-NF-κB/interleukin-6 pathway
Chia-Yu Chu et al.
CARCINOGENESIS (2009)
Suppression of NF-κB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells
Aeyung Kim et al.
CARCINOGENESIS (2009)
Targeting transcription factor NFκB Comparative analysis of proteasome and IKK inhibitors
Alexander V. Gasparian et al.
CELL CYCLE (2009)
PUMA is directly activated by NF-kappa B and contributes to TNF-alpha-induced apoptosis
P. Wang et al.
CELL DEATH AND DIFFERENTIATION (2009)
Constitutive NF-κB Activation in Colorectal Carcinoma Plays a Key Role in Angiogenesis, Promoting Tumor Growth
Kei Sakamoto et al.
CLINICAL CANCER RESEARCH (2009)
Targeting Inflammatory Pathways for Prevention and Therapy of Cancer: Short-Term Friend, Long-Term Foe
Bharat B. Aggarwal et al.
CLINICAL CANCER RESEARCH (2009)
A Randomized Phase 2 Study of Erlotinib Alone and in Combination with Bortezomib in Previously Treated Advanced Non-small Cell Lung Cancer
Thomas J. Lynch et al.
JOURNAL OF THORACIC ONCOLOGY (2009)
IKKβ-mediated nuclear factor-κB activation attenuates smac mimetic-induced apoptosis in cancer cells
Lang Lai et al.
MOLECULAR CANCER THERAPEUTICS (2009)
OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls
Veronique Baud et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
Updates on p53: modulation of p53 degradation as a therapeutic approach
A. Dey et al.
BRITISH JOURNAL OF CANCER (2008)
Multi-targeted prevention and therapy of cancer by proanthocyanidins
Vijayalakshmi Nandakumar et al.
CANCER LETTERS (2008)
TNF-α induces two distinct caspase-8 activation pathways
Lai Wang et al.
CELL (2008)
Proteasome inhibition activates epidermal growth factor receptor (EGFR) and EGFR-independent mitogenic kinase signaling pathways in pancreatic cancer cells
Callum M. Sloss et al.
CLINICAL CANCER RESEARCH (2008)
Luteolin, a Flavonoid with Potential for Cancer Prevention and Therapy
Yong Lin et al.
CURRENT CANCER DRUG TARGETS (2008)
Nuclear factor-kB activation: From bench to bedside
Gautam Sethi et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2008)
NF-kappaB: a potential target for cancer chemoprevention and therapy
Fazlul H. Sarkar et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor α (TNFα)-induced NF-κB activation
Eugene Varfolomeev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Blockage of NF-κB by IKKβ- or RelA-siRNA rather than the NF-κB super-suppressor IκBα mutant potentiates adriamycin-induced cytotoxicity in lung cancer cells
Wenshu Chen et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Jordi Rius et al.
NATURE (2008)
Noncanonical NF-kappa B activation requires coordinated assembly of a regulatory complex of the adaptors cIAP1, cIAP2, TRAF2 and TRAF3 and the kinase NIK
Brian J. Zarnegar et al.
NATURE IMMUNOLOGY (2008)
NSAIDs Downregulate Bcl-X-L and Dissociate BAX and Bcl-X-L to Induce Apoptosis in Colon Cancer Cells
Alexander Bank et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2008)
Interleukin-8 induction by the environmental contaminant benzo(a)pyrene is aryl hydrocarbon receptor-dependent and leads to lung inflammation
Normand Podechard et al.
TOXICOLOGY LETTERS (2008)
RelA/NF-κB recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells
R. Cianfrocca et al.
CELL DEATH AND DIFFERENTIATION (2008)
Nuclear factor-κB, an unappreciated tumor suppressor
Fei Chen et al.
CANCER RESEARCH (2007)
IAP antagonists induce autoubiquitination of c-IAPs, NF-κB activation, and TNFα-dependent apoptosis
Eugene Varfolomeev et al.
CELL (2007)
IAP antagonists target cIAP1 to induce TNFα- dependent apoptosis
James E. Vince et al.
CELL (2007)
A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-κB pathway and sensitization of apoptosis in lung cancer cells
Wei Ju et al.
MOLECULAR PHARMACOLOGY (2007)
Sensitization of TNF-induced cytotoxicity in lung cancer cells by concurrent suppression of the NF-κB and Akt pathways
Xia Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Oestrogen signalling inhibits invasive phenotype by repressing RelB and its target BCL2
Xiaobo Wang et al.
NATURE CELL BIOLOGY (2007)
Critical role for NF-κB-induced JunB in VEGF regulation and tumor angiogenesis
Dirk Schmidt et al.
EMBO JOURNAL (2007)
Role of dioxin response element and nuclear factor-kappa B motifs in 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated regulation of fas and fas ligand expression
Narendra P. Singh et al.
MOLECULAR PHARMACOLOGY (2007)
RIP1, a kinase on the crossroads of a cell's decision to live or die
N. Festjens et al.
CELL DEATH AND DIFFERENTIATION (2007)
Bortezomib (PS-341, Velcade) increases the efficacy of trastuzumab (Herceptin) in HER-2-positive breast cancer cells in a synergistic manner
Fatima Cardoso et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Regulation of inflammation and redox signaling by dietary polyphenols
Irfan Rahman et al.
BIOCHEMICAL PHARMACOLOGY (2006)
NF-κB regulation of endothelial cell function during LPS-induced toxemia and cancer
Tatiana Kisseleva et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Molecular functions and biological roles of hepatitis B virus x protein
Hong Tang et al.
CANCER SCIENCE (2006)
Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-κB in cancer cells:: Delineation of a novel pathway
Aman P. Mann et al.
CANCER RESEARCH (2006)
Nuclear factor-κB in cancer development and progression
Michael Karin
NATURE (2006)
Signals from within:: the DNA-damage-induced NF-κB response
S Janssens et al.
CELL DEATH AND DIFFERENTIATION (2006)
Activation of IKK by TNFα requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO
CK Ea et al.
MOLECULAR CELL (2006)
NEMO is a sensor of Lys 63-linked polyubiquitination and functions in NF-κB activation
CJ Wu et al.
NATURE CELL BIOLOGY (2006)
BMS-345541 targets inhibitor of κB kinase and induces apoptosis in melanoma:: Involvement of nuclear factor κB and mitochondria pathways
JM Yang et al.
CLINICAL CANCER RESEARCH (2006)
17-allylamino-17-demethoxygeldanamycin synergistically potentiates tumor necrosis factor-induced lung cancer cell death by blocking the nuclear Factor-κB pathway
X Wang et al.
CANCER RESEARCH (2006)
PIDD mediates NF-κB activation in response to DNA damage
S Janssens et al.
CELL (2005)
Inhibition of NF-κB activity by BAY 11-7082 increases apoptosis in multidrug resistant leukemic T-cell lines
MG García et al.
LEUKEMIA RESEARCH (2005)
NFκB:: Linking inflammation and immunity to cancer development and progression
M Karin et al.
NATURE REVIEWS IMMUNOLOGY (2005)
Activation of NF-κB by HTLV-I and implications for cell transformation
SC Sun et al.
ONCOGENE (2005)
Modulation of p53 activity by IκBα:: Evidence suggesting a common phylogeny between NF-κB and p53 transcription factors
DH Dreyfus et al.
BMC IMMUNOLOGY (2005)
Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases
H Kamata et al.
CELL (2005)
Tumor necrosis factor α-dependent drug resistance to purine and pyrimidine analogues in human colon tumor cells mediated through IKK
LC Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phase I study and pharmacokinetic of CHS-828, a guanidino-containing compound, administered orally as a single dose every 3 weeks in solid tumours: An ECSG/EORTC study
A Ravaud et al.
EUROPEAN JOURNAL OF CANCER (2005)
Phosphorylation of NF-kappa B and I kappa B proteins: implications in cancer and inflammation
P Viatour et al.
TRENDS IN BIOCHEMICAL SCIENCES (2005)
Active repression of antiapoptotic gene expression by ReIA(p65) NF-κB
KJ Campbell et al.
MOLECULAR CELL (2004)
NF-κB functions as a tumour promoter in inflammation-associated cancer
E Pikarsky et al.
NATURE (2004)
IKKβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer
FR Greten et al.
CELL (2004)
Epithelial-mesenchymal transition -: NF-κB takes center stage
MA Huber et al.
CELL CYCLE (2004)
Recruitment of IκBα to the hes1 promoter is associated with transcriptional repression
C Aguilera et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Lymphocyte transformation by Pim-2 is dependent on nuclear factor-κB activation
PS Hammerman et al.
CANCER RESEARCH (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
The nuclear factor κB subunits RelA/p65 and c-Rel potentiate but are not required for Ras-induced cellular transformation
JL Hanson et al.
CANCER RESEARCH (2004)
Inhibition of NFκB increases the efficacy of cisplatin in in vitro and in vivo ovarian cancer models
S Mabuchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Transfection of a dominant-negative mutant NF-κB inhibitor (IkBm) represses p53-dependent apoptosis in acute lymphoblastic leukemia cells:: interaction of IkBm and p53
MX Zhou et al.
ONCOGENE (2003)
CK2 is a C-terminal IκB kinase responsible for NF-κB activation during the UV response
T Kato et al.
MOLECULAR CELL (2003)
Inhibition of inducible NF-κB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line
H Uetsuka et al.
EXPERIMENTAL CELL RESEARCH (2003)
Signalling pathways of the TNF superfamily: A double-edged sword
BB Aggarwal
NATURE REVIEWS IMMUNOLOGY (2003)
The effect of adenovirus-IκBα transduction on the chemosensitivity of lung cancer cell line with resistance to cis-diamminedichloroplatinum(II)(cisplatin) and doxorubicin(adriamycin)
CT Lee et al.
LUNG CANCER (2003)
The death domain kinase RIP has an essential role in DNA damage-induced NF-κB activation
GM Hur et al.
GENES & DEVELOPMENT (2003)
I kappa B kinase-independent I kappa Ba degradation pathway: Functional NF-kappa B activity and implications for cancer therapy
V Tergaonkar et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Cigarette smoke condensate activates nuclear transcription factor-κB through phosphorylation and degradation of IκBα:: correlation with induction of cyclooxygenase-2
RJ Anto et al.
CARCINOGENESIS (2002)
Constitutive activation of NF-κB in Ki-ras-transformed prostate epithelial cells
BY Kim et al.
ONCOGENE (2002)
P53 stabilization is decreased upon NFκB activation:: A role for NFκB in acquisition of resistance to chemotherapy
V Tergaonkar et al.
CANCER CELL (2002)
NF-κB-mediated up-regulation of Bcl-XS and Bax contributes to cytochrome c release in cyanide-induced apoptosis
Y Shou et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Inhibition of NF-kappa B and proteasome activity in tumors: Can we improve the therapeutic potential of topoisomerase I and topoisomerase II poisons
R Ganapathi et al.
CURRENT PHARMACEUTICAL DESIGN (2002)
Inhibition of JNK activation through NF-κB target genes
GL Tang et al.
NATURE (2001)
The essential role of MEKK3 in TNF-induced NF-κB activation
JH Yang et al.
NATURE IMMUNOLOGY (2001)
Induction of Mdr1b expression by tumor necrosis factor-α in rat liver cells is independent of p53 but requires NF-κB signaling
JE Ros et al.
HEPATOLOGY (2001)
Bcl10 is a positive regulator of antigen receptor-induced activation of NF-κB and neural tube closure
J Ruland et al.
CELL (2001)
Role of NF-κB in p53-mediated programmed cell death
KM Ryan et al.
NATURE (2000)
Disruption of Hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-κB activation
J Lewis et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
The distinct roles of TRAF2 and RIP in IKK activation by TNF-R1: TRAF2 recruits IKK to TNF-R1 while RIP mediates IKK activation
A Devin et al.
IMMUNITY (2000)
Infections as a major preventable cause of human cancer
H Kuper et al.
JOURNAL OF INTERNAL MEDICINE (2000)
Share Paper
